How have CEROW shares performed this year?

CERo Therapeutics' stock was trading at $0.0899 on January 1st, 2024. Since then, CEROW stock has decreased by 93.3% and is now trading at $0.0060. View the best growth stocks for 2024 here .

How do I buy shares of CERo Therapeutics?

Shares of CEROW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CEROW

CERo Therapeutics (CEROW) Stock Price, News & Analysis

$0.0060

0.00 (-40.00%)

(As of 03:25 PM ET)

Compare

Today's Range: $0.0059
▼
$0.0073
50-Day Range: $0.01
▼
$0.03
52-Week Range: $0.01
▼
$0.25

Volume: 187,889 shs
Average Volume: 40,778 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Trends

Get CERo Therapeutics alerts:

Ad Behind the Markets

It’s over.

We found a tiny company which provides the backbone for the entire $15.7 trillion AI industry... It's used by EVERY single AI company on the planet... AMD, NVIDIA, META... none of these companies could exist without this firm.

Click here for the ticker >>>

About CERo Therapeutics

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.

CEROW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CEROW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive CEROW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CERo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:CEROW
CUSIP: N/A
CIK: 1870404
Web: www.cero.bio
Phone: 650-407-2376
Fax: N/A
Employees: 8
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: N/A
Beta: N/A

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

Key Executives

Dr. Daniel Mark Corey M.D. (Age 45)
Founder, CTO & Director
Comp: $376.04k
Mr. Brian G. Atwood (Age 71)
President, CEO & Chairman
Mr. Charles Ross Carter (Age 56)
CFO, Treasurer & Corporate Secretary
Dr. Robert Sikorski M.D. (Age 61)
Ph.D., Consultant

Key Competitors

View All Competitors

CEROW Stock Analysis - Frequently Asked Questions

How have CEROW shares performed this year?: CERo Therapeutics' stock was trading at $0.0899 on January 1st, 2024. Since then, CEROW stock has decreased by 93.3% and is now trading at $0.0060.
View the best growth stocks for 2024 here.
How do I buy shares of CERo Therapeutics?: Shares of CEROW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.